Curian Capital’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-31,900
Closed -$2.15M 115
2015
Q4
$2.15M Sell
31,900
-71,815
-69% -$5.02M 0.16% 142
2015
Q3
$6.71M Sell
103,715
-60,586
-37% -$4.47M 0.18% 138
2015
Q2
$13.4M Buy
164,301
+1,642
+1% +$127K 0.23% 114
2015
Q1
$11.3M Buy
162,659
+33,841
+26% +$2.44M 0.19% 133
2014
Q4
$9.77M Buy
128,818
+3,480
+3% +$275K 0.17% 151
2014
Q3
$10.1M Buy
125,338
+115,756
+1,208% +$9.66M 0.18% 132
2014
Q2
$837K Buy
9,582
+10
+0.1% +$869 0.01% 467
2014
Q1
$825K Buy
9,572
+463
+5% +$38K 0.01% 473
2013
Q4
$735K Buy
9,109
+1,416
+18% +$110K 0.01% 465
2013
Q3
$599K Buy
7,693
+4,004
+109% +$308K 0.01% 484
2013
Q2
$258K Buy
+3,689
New +$257K ﹤0.01% 547

Other funds holding EMN

Curian Capital's EMN Position: Q1 2016 in Review

Curian Capital sold out of Eastman Chemical (EMN) in Q1 2016, closing a stake of 31,900 shares — an estimated $2.15M sold.

Curian Capital first reported a position in EMN in Q2 2013 and held it in 11 quarters. The position peaked at $13.4M in Q2 2015. 572 funds tracked by Wall St. Rank hold EMN as of Q1 2016.

  • Curian Capital reported no remaining Eastman Chemical position as of Q1 2016 after selling out during the quarter.
  • Curian Capital sold 31,900 Eastman Chemical shares in Q1 2016, an estimated $2.15M.
  • Curian Capital first reported a position in Eastman Chemical in Q2 2013 and held it in 11 quarters.
  • Curian Capital's Eastman Chemical position peaked at $13.4M in Q2 2015.
  • 572 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.